GBA1 and Parkinson disease: Overall, the presence of severe homozygous GBA1 mutations led to a significantly higher amount of oligomeric α‐synuclein accumulation and release, which might explain the clinical severity and relatively rapid progression of PD in severe GBA1 mutant cases.